Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
EOLS
EOLS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EOLS News
BofA Raises Teradyne Price Target to $260 Amid Strong Buy Rating
Jan 22 2026
Benzinga
Evolus Provides 2026 Net Revenue Guidance, Forecasts 13% Growth
Jan 09 2026
Newsfilter
Stonepine Capital Fully Exits ANI Pharmaceuticals, Reporting $2.52 Million Loss
Dec 28 2025
Yahoo Finance
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead
Nov 06 2025
NASDAQ.COM
Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch
Sep 22 2025
PRnewswire
Evolus Reveals Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
Sep 12 2025
Newsfilter
BTIG Affirms Buy Rating for Evolus, Keeps $18 Price Target Intact
Sep 08 2025
Benzinga
Evolus Appoints Tatjana Mitchell as Chief Financial Officer
Sep 08 2025
Newsfilter
The Middle-Class Experience Has Transitioned from Stability to Strain
Aug 31 2025
WSJ
Evolus Shares Encouraging Results from Key Study on Evolysse Sculpt for Restoring Mid-Facial Volume
Aug 25 2025
NASDAQ.COM
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 08 2025
Newsfilter
Evolus plunges after Q2 miss, guidance cut; Needham downgrades
Aug 06 2025
SeekingAlpha
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Aug 06 2025
Benzinga
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Aug 06 2025
Benzinga
Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau® as a Top Performer Among Leading Neurotoxins
Jul 31 2025
Newsfilter
Thursday 6/12 Insider Buying Report: ARDX, EOLS
Jun 12 2025
NASDAQ.COM
Show More News
